Bone Core
Bone Core
批准号:
8854466
负责人:
Kenneth M Kozloff
金额:
$16.36万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-05 至 2020-05-31
关键词:
Animal ModelBiological ModelsBiologyBloodBone MarrowBone neoplasmsCell SeparationCellsClinicalConsultationsCore FacilityDecalcificationDiagnosisExperimental DesignsGoalsHistologicHistopathologyImage AnalysisImmunohistochemistryLesionMalignant neoplasm of prostateMetastatic Neoplasm to the BoneMethodsMicroradiographyNeoplasm Circulating CellsNeoplasm MetastasisParaffinParaffin EmbeddingPathologicPathologistPathologyPatientsPeripheralPhysiciansPlastic EmbeddingProcessResearch PersonnelResource SharingResourcesSamplingScientistSerumServicesSpecimenSpecimen HandlingStaining methodStainsTechniquesTissue SampleTissuesTrainingTumor TissueUrologic Oncologyboneneoplastic cellprogramssample fixationsoft tissuetissue processing
中文摘要
核心C:骨性核心
英文摘要
Core C: Bone Core
Project Summary
The Bone Core of the Program Project will provide shared facilities and services for procuring, processing and
interpretation of tissues from both clinical samples and animal models utilized in all projects of the program.
The following services will be provided: experimental design/consultation regarding endpoint analyses for
histologic specimens, processing of osseous tissues for histologic analysis (decalcified and undecalcified
sections, bone histomorphometric analysis of osseous sections (i.e. interpretation), and histologic analysis of
soft tissue metastases or other soft tissue lesions with their pathologic diagnosis. Additionally, procurement of
clinically-derived tissues, particularly disseminated tumor cells (DTC) from patients. In addition to histologic
support, the core will provide services of FAXITRON microradiography and peripheral QCT. The bone core will
continue providing expertise that includes the processing of soft tissue specimens and decalcified hard tissue
specimens in paraffin in addition to processing undecalcified osseous specimens using plastic embedding
techniques. Investigators will be provided with training and assistance in static and dynamic bone
histomorphometric analysis. Core support of these services will promote efficiency of specimen analysis and
facilitate interactions between projects through the similar model systems and their common analyses. A
significant benefit to the program as a group will be a standardized format for analysis of specimens from the
common animal models that will be using different experimental approaches/targets. This will provide valuable
information that can be shared and compared across the projects in the program. To accomplish these goals,
the core is directed by Dr. Kenneth Kozloff, who is an expert in bone biology. In addition, the core is supported
by Dr. Rohit Mehra, a board-certified urologic oncology pathologist and Dr. Todd Morgan, a physician scientist
with expertise in disseminated cell procurement and biology. Additional expertise in bone histomorphometry is
provided by our consultant Dr. Tom Wronski and tumor bone pathology by Dr. David Lucas, a U.Michigan
pathologist who specializes in bone tumors. Overall this core will continue to provide comprehensive and
unique services that are required by all the projects of this Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biologic signatures for sclerostin antibody responsiveness in human and murine models of osteogenesis imperfecta
-
批准号:9912070
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2019
-
负责人:Kenneth M Kozloff
-
依托单位:
In Vivo Micro-Computed Tomography Imaging System
-
批准号:8825618
-
项目类别:
-
资助金额:$39.29万
-
财政年份:2015
-
负责人:Kenneth M Kozloff
-
依托单位:
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta
-
批准号:8395429
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2012
-
负责人:Kenneth M Kozloff
-
依托单位:
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta
-
批准号:9081526
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2012
-
负责人:Kenneth M Kozloff
-
依托单位:
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta
-
批准号:9107616
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2012
-
负责人:Kenneth M Kozloff
-
依托单位:
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta
-
批准号:8698279
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2012
-
负责人:Kenneth M Kozloff
-
依托单位:
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta
-
批准号:8881955
-
项目类别:
-
资助金额:$33.76万
-
财政年份:2012
-
负责人:Kenneth M Kozloff
-
依托单位:
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta
-
批准号:8549107
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2012
-
负责人:Kenneth M Kozloff
-
依托单位:
Bone Turnover Effects on Bisphosphonate Concentration in the Mandible
-
批准号:8044437
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2011
-
负责人:Kenneth M Kozloff
-
依托单位:
Bone Turnover Effects on Bisphosphonate Concentration in the Mandible
-
批准号:8246394
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2011
-
负责人:Kenneth M Kozloff
-
依托单位:
Core C - Bone Core
-
批准号:10208789
-
项目类别:
-
资助金额:$22.57万
-
财政年份:2004
-
负责人:Kenneth M Kozloff
-
依托单位:
海外基金